Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Medicure (MCUJF) over the last 17 years, with Q3 2025 value amounting to $5.2 million.

  • Medicure's Cash & Equivalents rose 1189.0% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 1189.0%. This contributed to the annual value of $5.1 million for FY2024, which is 4428.79% up from last year.
  • According to the latest figures from Q3 2025, Medicure's Cash & Equivalents is $5.2 million, which was up 1189.0% from $5.2 million recorded in Q2 2025.
  • In the past 5 years, Medicure's Cash & Equivalents ranged from a high of $5.2 million in Q3 2025 and a low of $2.1 million during Q1 2021
  • Over the past 5 years, Medicure's median Cash & Equivalents value was $3.6 million (recorded in 2023), while the average stood at $3.6 million.
  • As far as peak fluctuations go, Medicure's Cash & Equivalents plummeted by 7782.34% in 2021, and later surged by 4428.79% in 2024.
  • Over the past 5 years, Medicure's Cash & Equivalents (Quarter) stood at $2.2 million in 2021, then increased by 26.3% to $2.7 million in 2022, then soared by 31.1% to $3.6 million in 2023, then soared by 44.29% to $5.1 million in 2024, then rose by 1.48% to $5.2 million in 2025.
  • Its Cash & Equivalents was $5.2 million in Q3 2025, compared to $5.2 million in Q2 2025 and $5.0 million in Q1 2025.